artemether plus lumefantrine

5 trials

Sponsors

Swiss Pharma Nigeria Limited, EDCTP, Pfizer Global pharmaceuticals, National Malarial and Vector Control, CERMEL

Conditions

MalariaMalaria Paediatrics

Phase 4

Efficacy and safety of artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in Gabon.

Active, not recruitingPACTR202511868232388

Start: 2025-11-01Target: 300Updated: 2026-09-14

Unknown Phase

Open randomized study for the evaluation of activities of AS/AQ (co-packaged and co-formulated) versus AL on asexual & sexual paraistes in children

Active, not recruitingPACTR201508001188143

Swiss Pharma Nigeria LimitedMalaria Paediatrics

Start: 2009-08-01Updated: 2026-09-14

Drug therapeutic efficacy testing

Active, not recruitingPACTR201510001189370

National Malarial and Vector ControlMalaria

Start: 2009-05-03Updated: 2026-09-14

Validation of New Biomarkers for Monitoring P. falciparum Reduced susceptibility/Tolerance or Resistance to Artemisinin Derivatives and Partner Drugs

Active, not recruitingPACTR201508001191898

Start: 2009-01-09Updated: 2026-09-14

Comparative study of the effect and tolerance of sulfalene/pyrimethamine/amodiaquine versus artemether/lumefantrine for treatment of malaria

Active, not recruitingPACTR201508001193368

Pfizer Global pharmaceuticalsMalaria

Start: 2005-11-01Updated: 2026-09-14

Related Papers

Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria

Infectious Diseases of Poverty2019-08-0619 citations

Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments.

2017-02-0712 citations

Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria

BMC Infectious Diseases2017-01-317 citations

Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.

2016-07-065 citations

Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.

2016-06-0111 citations

Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.

2015-10-2610 citations